INTERNATIONAL PATENT: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. FILES APPLICATION FOR "PURINE COVALENT BASED CDK12 INHIBITORS"

GENEVA, Nov. 5 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (12902 Magnolia DriveTampa, Florida 33612) filed a patent application (PCT/US2025/025995) for "PURINE COVALENT BASED CDK12 INHIBITORS" on Apr 23, 2025. With publication no. WO/2025/226831, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MONASTYRSKYI, Andrii (12902 Magnolia DriveTampa, Florida 33612), DUCKETT, Derek (12902 Magnolia DriveTampa, Florida 33612)

Abstract: Disclosed are purine derivatives of formulae (I), and pharmaceutically acceptabl...